| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.517 | 18.942 | 15.880 | 12.831 | 17.092 | 17.747 | 11.085 | 13.798 | 12.467 | 12.057 |
| Total Income - EUR | 18.517 | 18.942 | 17.337 | 17.808 | 17.092 | 19.246 | 11.085 | 13.798 | 12.467 | 12.057 |
| Total Expenses - EUR | 17.883 | 17.063 | 15.358 | 16.975 | 14.798 | 15.699 | 7.170 | 10.572 | 8.812 | 9.101 |
| Gross Profit/Loss - EUR | 634 | 1.879 | 1.979 | 833 | 2.294 | 3.546 | 3.915 | 3.225 | 3.655 | 2.956 |
| Net Profit/Loss - EUR | 76 | 1.428 | 1.803 | 635 | 2.110 | 2.969 | 3.741 | 2.811 | 3.263 | 2.483 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aphroditae Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.664 | 15.921 | 15.869 | 14.895 | 13.937 | 13.017 | 12.086 | 11.480 | 10.803 | 10.226 |
| Current Assets | 9.393 | 5.728 | 5.296 | 7.567 | 5.716 | 8.712 | 13.263 | 17.659 | 18.910 | 23.414 |
| Inventories | 8.019 | 4.985 | 3.994 | 5.483 | 4.897 | 2.483 | 1.888 | 1.972 | 1.790 | 2.344 |
| Receivables | 1.342 | 742 | 1.255 | 2.071 | 804 | 706 | 970 | 1.587 | 1.917 | 2.371 |
| Cash | 32 | 1 | 47 | 13 | 16 | 5.522 | 10.405 | 14.100 | 15.203 | 18.700 |
| Shareholders Funds | 12.200 | 13.504 | 15.078 | 15.437 | 17.248 | 19.890 | 23.190 | 26.073 | 29.257 | 31.576 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.867 | 10.738 | 8.804 | 9.969 | 8.678 | 1.839 | 2.160 | 3.066 | 457 | 2.064 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Aphroditae Srl